“ Our goal is to generate rigorous clinical data demonstrating that these therapies can deliver meaningful and lasting benefits for patients ”
In Conversation
“ The concept of a modern CRO begins with understanding what modern biotech companies actually need ”
“ In this field, success depends on the integrity of the whole system, not on any single element within it ”
Olivier Dessajan – General Manager, China Merchants – Colisée; Co-President, French Healthcare Alliance, China
“ European companies no longer see China only as a market or as a source of cheap equipment – they see it as a genuine innovation hub… ”
“ We want to make gene therapy not only innovative, but also accessible and affordable for patients, especially in markets where access is still limited ”
“ Success for Biosion will be building a sustainable innovation company that knows where to lead, where to collaborate, and how to create value consistently ”
“ If the data reflect what we have seen preclinically, we believe our approach could create meaningful opportunities well beyond our initial liver and T-cell programmes ”
“ China's role has evolved from being purely a commercial access market to becoming a genuine co-creation partner ”
“ Our philosophy is to translate scientific excellence into therapies that are not only effective and safe, but also accessible to a broader patient population ”
“ bioBAY’s reputation rests not on its infrastructure, but on the companies that grow within the ecosystem and carry its name onto the global stage ”
“ It is not only about developing what we find scientifically interesting, but also about understanding what potential partners are looking for ”
“ Execution alone does not create value. Without deep biological insight, speed simply produces more of the same ”
